AlphaYouYM
Insider buying
Yezan Munther Haddadin bought $24K of Outlook Therapeutics, Inc. (OTLK) stock
Yezan Munther Haddadin, Dir of Outlook Therapeutics, Inc. (OTLK), bought 29,000 shares of OTLK stock worth $24K, per an SEC Form 4 filed Jun 3, 2026.
It was an open-market purchase.
The trade happened on Jun 2, 2026, 1 day before it was made public.
OTLK has moved -15.6% since the trade date, from $0.81 to $0.69 (Sep 21, 2026 close).
- Traded
- Jun 2, 2026
- Disclosed
- Jun 3, 2026
- Filing delay
- 1 day
- Price since
- -15.6%
- Role
- Dir
- Source
- SEC Form 4
More OTLK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.